172 related articles for article (PubMed ID: 22531957)
1. The prevalence of detrusor overactivity amongst patients with symptoms of overactive bladder: a retrospective cohort study.
Diamond P; Hassonah S; Alarab M; Lovatsis D; Drutz HP
Int Urogynecol J; 2012 Nov; 23(11):1577-80. PubMed ID: 22531957
[TBL] [Abstract][Full Text] [Related]
2. Overactive bladder syndrome - focus onto detrusor overactivity.
Ptashnyk T; Hatzinger M; Zeller FL; Kirschner-Hermanns R
Scand J Urol; 2021 Feb; 55(1):56-60. PubMed ID: 33118417
[TBL] [Abstract][Full Text] [Related]
3. Is there a difference between women with or without detrusor overactivity complaining of symptoms of overactive bladder?
Giarenis I; Mastoroudes H; Srikrishna S; Robinson D; Cardozo L
BJU Int; 2013 Aug; 112(4):501-7. PubMed ID: 23452071
[TBL] [Abstract][Full Text] [Related]
4. Clinical and urodynamic impact of detrusor overactivity in women with overactive bladder.
Jiménez-Cidre MA; López-Fando L; Mora AM;
Actas Urol Esp (Engl Ed); 2019 Jun; 43(5):221-227. PubMed ID: 30862379
[TBL] [Abstract][Full Text] [Related]
5. A Comprehensive Review of Overactive Bladder Pathophysiology: On the Way to Tailored Treatment.
Peyronnet B; Mironska E; Chapple C; Cardozo L; Oelke M; Dmochowski R; Amarenco G; Gamé X; Kirby R; Van Der Aa F; Cornu JN
Eur Urol; 2019 Jun; 75(6):988-1000. PubMed ID: 30922690
[TBL] [Abstract][Full Text] [Related]
6. Urodynamic findings in women with refractory overactive bladder symptoms.
Al-Zahrani AA; Gajewski J
Int J Urol; 2016 Jan; 23(1):75-9. PubMed ID: 26417863
[TBL] [Abstract][Full Text] [Related]
7. Association of symptoms with urodynamic findings in men with overactive bladder syndrome.
Al-Zahrani AA; Gajewski JB
BJU Int; 2012 Dec; 110(11 Pt C):E891-5. PubMed ID: 22928556
[TBL] [Abstract][Full Text] [Related]
8. Does urodynamic verification of overactive bladder determine treatment success? Results from a randomized placebo-controlled study.
Malone-Lee JG; Al-Buheissi S
BJU Int; 2009 Apr; 103(7):931-7. PubMed ID: 19281469
[TBL] [Abstract][Full Text] [Related]
9. Pre-operative opening detrusor pressure is predictive of detrusor overactivity following TVT in patients with pre-operative mixed urinary incontinence.
Panayi DC; Duckett J; Digesu GA; Camarata M; Basu M; Khullar V
Neurourol Urodyn; 2009; 28(1):82-5. PubMed ID: 19089898
[TBL] [Abstract][Full Text] [Related]
10. Is sensory urgency part of the same spectrum of bladder dysfunction as detrusor overactivity?
Haylen BT; Chetty N; Logan V; Schulz S; Verity L; Law M; Zhou J
Int Urogynecol J Pelvic Floor Dysfunct; 2007 Feb; 18(2):123-8. PubMed ID: 16823541
[TBL] [Abstract][Full Text] [Related]
11. Are patients with the symptoms of overactive bladder and urodynamic detrusor overactivity different from those with overactive bladder but not detrusor overactivity?
Fan YH; Lin CC; Lin AT; Chen KK
J Chin Med Assoc; 2011 Oct; 74(10):455-9. PubMed ID: 22036137
[TBL] [Abstract][Full Text] [Related]
12. Clinical and urodynamic differences among women with overactive bladder according to the presence of detrusor overactivity.
Jeong SJ; Lee SC; Jeong CW; Hong SK; Byun SS; Lee SE
Int Urogynecol J; 2013 Feb; 24(2):255-61. PubMed ID: 22588142
[TBL] [Abstract][Full Text] [Related]
13. OAB score: a clinical model that predicts the probability of presenting overactive detrusor in the urodynamic study.
Arribillaga LC; Ledesma M; Montedoro A; Pisano F; Bengió RG
Int Braz J Urol; 2018; 44(2):348-354. PubMed ID: 29211399
[TBL] [Abstract][Full Text] [Related]
14. [The influence of mesh pelvic floor reconstructive surgery on OAB symptoms].
Nowakowski L; Wróbel A; Jankiewicz K; Kulik-Rechberger B; Rechberger T
Ginekol Pol; 2014 Oct; 85(10):760-4. PubMed ID: 25546927
[TBL] [Abstract][Full Text] [Related]
15. Ambulatory urodynamic monitoring of women with overactive bladder syndrome during single voiding cycle.
Dokmeci F; Cetinkaya SE; Seval MM; Dai O
Eur J Obstet Gynecol Reprod Biol; 2017 May; 212():126-131. PubMed ID: 28355584
[TBL] [Abstract][Full Text] [Related]
16. Electromotive drug-administration: a pilot study for minimal-invasive treatment of therapy-resistant idiopathic detrusor overactivity.
Bach P; Wormland RT; Möhring C; Goepel M
Neurourol Urodyn; 2009; 28(3):209-13. PubMed ID: 19205067
[TBL] [Abstract][Full Text] [Related]
17. Role of botulinum toxin-A in refractory idiopathic overactive bladder patients without detrusor overactivity.
Kanagarajah P; Ayyathurai R; Caruso DJ; Gomez C; Gousse AE
Int Urol Nephrol; 2012 Feb; 44(1):91-7. PubMed ID: 21643644
[TBL] [Abstract][Full Text] [Related]
18. Overactive bladder in an integrated delivery system: a longitudinal cohort study.
Linder JA; Weissman JS; Reyes Nieva H; Lipsitz S; Haring RS; DeAngelis J; Kristy RM; Loughlin KR
BMC Health Serv Res; 2020 May; 20(1):447. PubMed ID: 32434511
[TBL] [Abstract][Full Text] [Related]
19. Urodynamics in the evaluation of overactive bladder.
Rovner ES; Goudelocke CM
Curr Urol Rep; 2010 Sep; 11(5):343-7. PubMed ID: 20585906
[TBL] [Abstract][Full Text] [Related]
20. Are patients with bladder oversensitivity different from those with urodynamically proven detrusor overactivity in female overactive bladder syndrome?
Chen SL; Ng SC; Huang YH; Chen GD
J Chin Med Assoc; 2017 Oct; 80(10):644-650. PubMed ID: 28757173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
